Nothing ever posted is financial advice | Do your own due diligence | Only innovation prevents chaos.
https://t.co/kfXZOyo0E7chaotropy.com EarthJoined July 2024
@Ahmet_S_Ozcan Thank you for creating this fantastic dataset! I used it extensively in my latest article on the limits of non-physical intelligence. Would love to hear your thoughts.
chaotropy.substack.com/p/non-physical…
Lately I see a lot of hype posts on $TENX and the upcoming phase 3 readout of oral levosimendan in PH-HFpEF. I am not sure I like that, despite being long $TENX myself.
This is a pure binary, and it may not even be possible to say with any certainty whether it is anywhere close
Today, we announced our second quarter 2026 financial results and shared our latest business updates. Read our press release to learn more about our commercial progress and updates on our RAS/MAPK pathway driven pipeline programs.
investor.verastem.com/news-releases/…#VerastemOnc
Woe unto him that saith to the wood, ‘Awake!’ To the dumb stone, ‘Arise, it shall teach!’ Behold, it is laid over with gold and silver, and there is no breath at all in the midst of it. Habakkuk 2:19, King James Bible
@zoink Woe unto him that saith to the wood, ‘Awake!’ To the dumb stone, ‘Arise, it shall teach!’ Behold, it is laid over with gold and silver, and there is no breath at all in the midst of it.
Habakkuk 2:19, King James Bible
Somehow I missed this insightful interview with $CUE's new CEO, Dr. Shao-Lee Lin, when @LouBasenese published it in June. Really worth watching if you’re following CUE-221 and CUE-401.
Disclosure: I am long $CUE. This is not financial advice. Do your own research.
"Food freedom."
That's what @CueBiopharma CEO Dr. Shao-Lee Lin says $CUE is designed to deliver - not just allergy management.
An IgE modulator targeting the root cause. Single-dose holding for 14+ weeks. Phase 2 data release in H2 2026.
This full episode of The Upside
That’s by the way one of the reasons why I am long $PLTR. AI performance might just hit a ceiling and models might commoditize. The value is then in the deployment layer. This is not financial advice. Do your own research.
I might die on that hill, but outside of coding, Fable 5 seems vastly overrated to me. Prompt it to write a coherent article on a complex subject and you get the same AI slop as every model before.
For weeks the only acceptable reaction to Fable was echoing the hype. Say
Lately I see a lot of hype posts on $TENX and the upcoming phase 3 readout of oral levosimendan in PH-HFpEF. I am not sure I like that, despite being long $TENX myself.
This is a pure binary, and it may not even be possible to say with any certainty whether it is anywhere close to a coin flip.
We have very thin phase 2 data which might not translate or even just be noise, generated in a different population using a different formulation and route of administration, in a relatively recently described and not well understood disease.
I like simulating stuff, but in my opinion a simulation like this can at most show that an outcome is plausible, and says not much about how likely it is. The human organism is far too complex and too heterogeneous for reliable predictions.
This is not financial advice. I am long $TENX. Do your own research.
$TENX announced on July 2 that the Phase 3 LEVEL results will be presented at ESC in Munich on August 29.
In March I built a computational simulation of oral TID levosimendan (what they're using in phase 3) versus the weekly IV dosing from the phase 2 study. Figure from my
I might die on that hill, but outside of coding, Fable 5 seems vastly overrated to me. Prompt it to write a coherent article on a complex subject and you get the same AI slop as every model before.
For weeks the only acceptable reaction to Fable was echoing the hype. Say anything short of “wow, this changes everything” and people decide you don’t know what you’re talking about. Kind of like the emperor’s new clothes.
The growth of $PLTR’s revenue is still growing. That’s the second derivative. Apparently demand is surging for the brains of organizations that $PLTR builds.
Disclosure: I am long $PLTR. This is not financial advice. Do your own research.
223 Followers 939 FollowingMan from Adelaide. Interested in political and economic theory, poverty and the welfare system. The welfare state crushes poverty!
215 Followers 2K FollowingCommentary on AI, science, talk of the day and matters of the heart. Internet flâneur, aspiring secondary source. Views my own. 2nd acc: @DJspapers
15K Followers 2K FollowingIncoming prof @UCBerkeley
AI agents, policy, evals, AI for science
Essay/newsletter (AI as Normal Technology): https://t.co/5amOkqLb4A
Book (AI Snake Oil): https://t.co/DabpkhNZ2k
129K Followers 553 FollowingPrinceton CS prof and Director @PrincetonCITP.
Coauthor of "AI Snake Oil" and "AI as Normal Technology". https://t.co/ZwebetjZ4n
Views mine.
1.7M Followers 2 FollowingClaude is an AI assistant built by @anthropicai to be safe, accurate, and secure. Talk to Claude on https://t.co/ZhTwG8dz3D or download the app.
1.5M Followers 221 FollowingDoctor of Dietetics 👩🎓 Supermodel 😉💃 [email protected]
Author: A Woman Makes A Plan 📖 +Sept 2026 TIMELESS 📖
Pre-order: https://t.co/W9KRc2KNbf
47K Followers 130 FollowingWe’re building quiet, all-electric aircraft to connect people like never before. Flying together with @flybladenow
$JOBY https://t.co/FBnudr5q9F
8K Followers 566 FollowingBiotech advisor @Pharmagellan. Professor of the Practice of Biotech @tufts_biology. Lurking here; posting at @franksdavid.bsky.social.
1.1M Followers 2K FollowingI am a technology enthusiast, writer, and modder. Founder of @ModRetro, @Oculus VR, and @Anduriltech. Keeping American superheroes safe with autonomous systems.
12K Followers 220 FollowingSivers Semiconductors enables a greener data economy with energy-efficient photonics and wireless solutions, supporting AI, SATCOM, Defense, and Telecom.
2K Followers 32 FollowingOfficial account for news & info on Summit Therapeutics, Inc., a biotech targeting significant, unmet medical needs, focused on oncology.
1.3M Followers 1K FollowingTechnology's daily show. Hosted by @johncoogan & @jordihays. Streaming live 11a-2p PT every weekday. Sign up for our free daily newsletter at https://t.co/Nhf5ohjInO.
28K Followers 32 FollowingWorks in Progress is a magazine of new and underrated ideas to improve the world. Subscribe to our new print edition now. We are proud to be part of @Stripe.
102K Followers 3K FollowingScience for a healthier tomorrow. Medical innovation for people and animals. #LifeForward
Community Guidelines: https://t.co/d5aGI1ZS8e
1K Followers 0 FollowingWe aim to revolutionize RAS-addicted cancer care through discovery, development, and delivery of innovative targeted medicines. #WeAreRevolutionaries
1K Followers 479 FollowingGI Oncologist @MayoClinicAZ | Trial synthesis, NET/NEN, upper GI, less is more & GI oncology | Mentor | Runner 🏃♂️ | Views my own, not @MayoClinic
355K Followers 1K FollowingWar Scholar | Chair of War Studies Madison Policy Forum | Executive Director @urbanwarfareins | UWP podcast | Thoughts/Posts my own RT/Quote/Like ≠ Official Gov
1.6M Followers 2 FollowingWe're an AI safety and research company that builds reliable, interpretable, and steerable AI systems. Talk to our AI assistant @claudeai on https://t.co/FhDI3KQh0n.
3K Followers 1K FollowingVerastem Oncology is committed to developing and commercializing medicines to improve the lives of patients with #RAS/MAPK-driven #cancers. $VSTM
2K Followers 276 Followingmd candidate @yalemed, writing at https://t.co/gffDMMDkZR, prev @delfidiagnostic @ibmresearch and math @johnshopkins. Views my own.
12K Followers 388 FollowingFounder of ROTY Biotech Community (500+ investors & traders) | Hobo | Not Prince Harry. Proverbs 21:31 - On a journey from mess to masterpiece. Trade to live 🤝